ArticleBMC public health2026
Estimating the hospitalisation burden of obesity in Europe: evidence from the European health interview survey (EHIS) wave 3.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundObesity represents a significant public health and economic challenge across Europe, driving an increased chronic disease burden and increased hospital utilisation. Despite this impact, cross-national evidence quantifying obesity’s hospitalisation burden remains sparse, and there is only a limited understanding of the potential cost savings achievable through obesity prevalence reduction.
methodsWe analysed European Health Interview Survey (EHIS) Wave 3 (2019) data, encompassing adults aged 18 years and older across eight countries (Belgium, the Netherlands, Germany, Luxembourg, Spain, Italy, Portugal and Denmark). Our primary outcome was the number of hospital nights in the preceding 12 months. We employed negative binomial regression models with zero-inflated specifications to estimate the associations between hospitalisation and body mass index (BMI), alongside sociodemographic, health and lifestyle factors. Simulations were used to project the impacts of a 1% obesity prevalence reduction on hospital expenditures.
resultsCompared to normal weight, obesity and underweight were strongly associated with increased hospital nights (IRR = 1.19 and 1.92, respectively), while pre-obesity showed no such association. Hospitalisation increased markedly with age, whereas higher education and income provided protective effects in this regard, reducing stays by 7% and 8%, respectively. Hypertension, diabetes and depressive symptoms substantially elevated hospital utilisation, while physical activity reduced it by 28%. Regional variation emerged, with Southern and Northern Europe reporting lower rates than Western Europe. A 1% obesity prevalence reduction would yield €4.27 billion in annual savings, representing 1.71% of combined hospital budgets.
conclusionsObesity and underweight significantly increase hospitalisation across Europe, placing substantial strain on health systems. Preventive strategies that promote healthy weight, physical activity and mental health could markedly reduce hospital demand and generate major economic savings. Even modest reductions in obesity prevalence offer strong health and fiscal benefits, underscoring the importance of sustained investment in prevention-focused public health policies intended to increase equity and healthcare sustainability across European countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.